PCOS Diagnostic Market is expected to Grow at 6.54% through 2030F

Increasing prevalence of PCOS among women is expected to drive Global PCOS Diagnostic Market in the forecast period, 2026-2030.

According to TechSci Research report, “PCOS Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F”, Global PCOS Diagnostic Market was valued at USD 4.76 billion in 2024 and is expected to reach USD 6.91 billion by 2030 with a CAGR of 6.54% during the forecast period. This can be ascribed to the growing number of PCOS cases across the world. PCOS is the most common endocrine disorder among the women of reproductive age (15-49 years). According to the Centers for Disease Control & Prevention (CDC) May 2022, PCOS is the most common cause of infertility among women.

The National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH)/European Society of Human Reproduction and Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM) accompanied by the Androgen Excess Society (AES) Criteria (2006) provided a diagnostic criterion for PCOS including Hyperandrogenism, Oligo-ovulation/anovulation, Polycystic ovaries and exclusion of other related disorders, as factors to be met for the diagnosis of PCOS.

Besides, sudden outbreak and spread of pandemic COVID-19 has increased the count for PCOS patients, as it is a symptomatic illness, the physical and mental health of women affected by the COVID-19 epidemic and the associated lockdown procedures was highly grown more negative. Therefore, the pandemic and its associated restrictions had a disproportionately negative effect on women who typically received care from various main and specialist healthcare facilities.

One of the primary factors driving the market expansion in North America is the rise in PCOS cases, caused by the prevalence of obesity and overweight people. Obesity, being considered a major risk factor for PCOS, has seen a surge during the pandemic. According to a report (September 2020) supplied by the Centers for Disease Control and Prevention (CDC), adult obesity prevalence is rising as a result of work-from-home culture, a decline in physical activity, and adult population stress. 

Also, there have been several initiatives by private and government firms to increase awareness about the disease, which is also expected to drive the market. However, this high incidence and its connection to ovulation and menstruation abnormalities, infertility, hair loss, and metabolic difficulties emphasize the significant financial burden caused by PCOS and could therefore restrain the global PCOS diagnostic market over the course of the projected period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "PCOS Diagnostic Market"

Global PCOS Diagnostic Market can be segmented by the type of test, by end user and by region.

Based on end user, the Global PCOS Diagnostic Market can be segmented into hospital & clinics, fertility clinics, and others. The hospital & clinics segment is dominating the market in 2022 and will maintain its dominance throughout the forecast period. This can be attributed to the growing number of patient admissions in these facilities suffering from various symptoms leading to PCOS. Generally, patients’ traction is more in Hospitals & Clinics as most women suffering from symptoms related to PCOS, visit common physicians, dermatologists, endocrinologists, infertility experts and gynecologists available in the Hospital & Clinics premises for the diagnosis.

Based on region, The Asia-Pacific (APAC) region dominates the global PCOS diagnostic market due to several key factors. First, the rising prevalence of PCOS in countries like India and China, driven by factors such as lifestyle changes, obesity, and genetic predisposition, has led to increased demand for diagnostic services. The growing awareness of PCOS among women and healthcare providers is contributing to earlier diagnosis and treatment, further boosting market growth. Another significant driver is the expanding healthcare infrastructure in the region, which improves access to advanced diagnostic tools and technologies. With increasing disposable incomes and healthcare spending, many APAC countries are improving diagnostic capabilities, allowing more women to seek timely and accurate diagnoses.

Also, the high number of reproductive-age women in the region, combined with the rising awareness of women's health issues, makes the APAC market a key focus for diagnostic companies. These factors collectively make APAC a dominant player in the global PCOS diagnostic market.

Major companies operating in the Global PCOS Diagnostic Market are:

·         Siemens Healthineers AG

·         GE Healthcare

·         Mindray Medical International Limited

·         Esaote S.p.A

·         Telemed Medical Systems

·         Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)

·         BK Medical

·         Alpinion Medical Systems

·         Mindray ZONARE Medical Systems

·         Xianfeng Ultrasound Medical

Companies operating in the market are following strategies such as continuously innovating tools to improve image quality and create specialized clinical tools to help the patients see more anatomical detail with greater certainty, enabling them to provide the best possible patient care, in order to stay competitive and have an edge over other players operating in the industry.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America is expected to dominate in the Global PCOS Diagnostic Market during the forecast period on account of increasing prevalence of PCOS. Besides, increasing healthcare expenditure and flourishing healthcare industry in the region are further expected to support the market growth in the region” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“PCOS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Blood Test, Pelvic Exam, Ultrasound Transvaginal)), By End User (Hospital & Clinics, Fertility Clinics, Others), and CompetitionBy Region”, has evaluated the future growth potential of Global PCOS Diagnostic Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global PCOS diagnosis market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com